期刊
AUTOIMMUNITY REVIEWS
卷 10, 期 11, 页码 664-668出版社
ELSEVIER
DOI: 10.1016/j.autrev.2011.04.031
关键词
Catastrophic antiphospholipid syndrome; Refractory; Anticardiolipin antobodies; Lupus anticoagulant; Rituximab; Defibrotide; Eculizumab
类别
The catastrophic variant of the antiphospholipid syndrome (APS) is the most severe form of APS with acute multiple organ involvement and small vessel thrombosis. Refractory catastrophic APS may be defined as patients who did not respond to first-line therapies (anticoagulation, glucocorticoids and plasma exchange and/or intravenous immunoglobulins) and died in the acute phase of the episode or patients with recurrent episodes of catastrophic APS. The purpose of this review is to focus on the current management of these refractory patients and some of the potential new therapeutic approaches. (C) 2011 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据